论文信息 - Use of everolimus in de novo renal recipients: initial experience in the Greek population. - 字舞流文

Use of everolimus in de novo renal recipients: initial experience in the Greek population.

D. Giakoustidis | D. Vrochides | A. Ntinas | V. Papanikolaou | F. Solonaki | A. Papagiannis | G. Miserlis | N. Antoniadis | I. Fouzas | P. Margari | G. Vergoulas | N. Ouzounidis | D. Takoudas | G. Imvrios

[1] J. Ehrich,et al. Reversal of loss of glomerular filtration rate in children with transplant nephropathy after switch to everolimus and low‐dose cyclosporine A , 2007, Pediatric transplantation.

[2] W. Weimar,et al. Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3] S. Mulgaonkar,et al. Everolimus versus Mycophenolate Mofetil in the Prevention of Rejection in De Novo Renal Transplant Recipients: A 3-Year Randomized, Multicenter, Phase III Study , 2005, Transplantation.

[4] Julio Pascual,et al. Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5] J. Pascual. [Everolimus: immunosuppression with antilymphoproliferative therapy]. , 2004, Nefrología.

[6] R. Oberbauer,et al. SIROLIMUS ALLOWS EARLY CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION RESULTING IN IMPROVED RENAL FUNCTION AND LOWER BLOOD PRESSURE1,2,10 , 2001, Transplantation.

[7] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .